We are live on ! Find out more
EAM

EULAV Asset Management Portfolio holdings

AUM $3.13B
1-Year Est. Return 23.04%
This Fund
S&P 500
This Quarter Est. Return
+1.68%
1 Year Est. Return
+23.04%
3 Year Est. Return
+90.7%
5 Year Est. Return
+115.08%
10 Year Est. Return
+583.23%
AUM
$3.73B
AUM Growth
-$93.7M
Cap. Flow
-$107M
Cap. Flow %
-2.87%
Top 10 Hldgs %
17.98%
Holding
245
New
4
Increased
54
Reduced
58
Closed
8

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$15.8M
2
DKNG icon
DraftKings
DKNG
+$12.9M
3
EXEL icon
Exelixis
EXEL
+$12.9M
4
V icon
Visa
V
+$11.6M
5
BAC icon
Bank of America
BAC
+$6.9M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$23.1M
2
AZO icon
AutoZone
AZO
+$20.7M
3
HEI icon
HEICO Corp
HEI
+$12.4M
4
AME icon
Ametek
AME
+$11.8M
5
AVGO icon
Broadcom
AVGO
+$11.6M

Sector Composition

Rank Sector Weight
1 Technology 34.35%
2 Healthcare 16.01%
3 Industrials 15.03%
4 Financials 11.96%
5 Consumer Discretionary 10.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADP icon
101
Automatic Data Processing
ADP
$106B
$11.3M 0.3%
59,900
– –
SPSC icon
102
SPS Commerce
SPSC
$2.64B
$10.4M 0.28%
104,500
– –
DG icon
103
Dollar General
DG
$28B
$10.4M 0.28%
51,105
– –
RBC icon
104
RBC Bearings
RBC
$17.4B
$10.3M 0.28%
52,500
– –
EW icon
105
Edwards Lifesciences
EW
$49.6B
$10.3M 0.28%
123,000
-7,000
-5% -$592K
FFIN icon
106
First Financial Bankshares
FFIN
$5.04B
$9.65M 0.26%
206,496
– –
COO icon
107
Cooper Companies
COO
$14.1B
$9.49M 0.25%
98,800
– –
PLUS icon
108
ePlus
PLUS
$2.42B
$9.36M 0.25%
187,800
– –
DPZ icon
109
Domino's
DPZ
$11.5B
$9.3M 0.25%
25,300
-5,000
-17% -$1.85M
GPN icon
110
Global Payments
GPN
$23B
$9.25M 0.25%
45,887
-9
-0% -$1.79K
BMY icon
111
Bristol-Myers Squibb
BMY
$133B
$8.53M 0.23%
135,084
-19,994
-13% -$1.24M
CSGP icon
112
CoStar Group
CSGP
$11.7B
$8.47M 0.23%
103,040
– –
IPHI
113
DELISTED
INPHI CORPORATION
IPHI
$8.42M 0.23%
47,217
– –
AAON icon
114
Aaon
AAON
$7.3B
$8.34M 0.22%
178,650
– –
USPH icon
115
US Physical Therapy
USPH
$1.2B
$8.1M 0.22%
77,800
– –
SLGN icon
116
Silgan Holdings
SLGN
$4.23B
$8.01M 0.21%
190,618
– –
ENS icon
117
EnerSys
ENS
$6.78B
$7.78M 0.21%
85,700
– –
BIO icon
118
Bio-Rad Laboratories Class A
BIO
$8.71B
$7.77M 0.21%
13,610
-9
-0.1% -$5.33K
EXLS icon
119
EXL Service
EXLS
$5.14B
$7.77M 0.21%
431,000
– –
ICPT
120
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$7.73M 0.21%
335,000
– –
HD icon
121
Home Depot
HD
$331B
$7.63M 0.2%
25,011
+9,996
+67% +$2.76M
MPWR icon
122
Monolithic Power Systems
MPWR
$70.1B
$7.62M 0.2%
21,565
-8
-0% -$2.91K
PLAN
123
DELISTED
Anaplan, Inc.
PLAN
$7.52M 0.2%
139,649
– –
COUP
124
DELISTED
Coupa Software Incorporated
COUP
$7.51M 0.2%
29,503
– –
RNR icon
125
RenaissanceRe
RNR
$13.3B
$7.37M 0.2%
46,000
-31,000
-40% -$5.01M
3 4
5
6 7

Similar funds

LFG
Larson Financial Group St Louis, Missouri $3.13B AUM 22.88% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.12B AUM 12.93% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CCI
Cevian Capital II St. Helier, Jersey $3.12B AUM 25.62% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return

EULAV Asset Management's Q1 2021 Portfolio in Review

As of Q1 2021, EULAV Asset Management held 245 positions worth $3.73B, down 2.4% from $3.83B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Trading was light in Q1 2021: portfolio turnover was 4.9%. EULAV Asset Management opened 4 new positions and exited 8, leaving the 245-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 34% a quarter earlier, followed by Healthcare and Industrials.

  • EULAV Asset Management's largest Q1 2021 buy was DraftKings: 215,000 shares worth $13.2M.
  • EULAV Asset Management added most to Vertex Pharmaceuticals in Q1 2021, an estimated $15.8M increase.
  • EULAV Asset Management's biggest Q1 2021 reduction was AutoZone, cutting an estimated $20.7M.
  • EULAV Asset Management fully exited Alexion Pharmaceuticals in Q1 2021, selling an estimated $23.1M.
  • EULAV Asset Management's ten largest holdings make up 18% of its $3.73B portfolio in Q1 2021.
  • EULAV Asset Management opened 4 new positions and closed 8 in Q1 2021.
  • EULAV Asset Management's portfolio value fell 2.4% quarter-over-quarter to $3.73B.

Based on EULAV Asset Management's 13F filing for Q1 2021, filed 30 Apr 2021.